Development and validation of an ultrasensitive qPCR method to identify and quantify EGFR T790M in cell-free DNA

Background Circulating tumor DNA (ctDNA) is a promising biomarker for cancer prognosis and drug development. A major challenge in the ctDNA determination method is discriminating ctDNA from highly similar but significantly more abundant wild-type DNA sensitively and accurately.